Results 21 to 30 of about 1,764,877 (337)
Lymph node characteristics of 6279 N1 differentiated thyroid cancer patients
Endocrine Connections, 2020 Purpose: This study examined the clinicopathological characteristics of 6279 N1 differentiated thyroid cancer (DTC) patients who underwent opera tions in our center. Methods: This was a retrospective longitudinal analysis.
C Sui +7 more
doaj +1 more source
Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.
Thyroid, 2015 INTRODUCTION The American Thyroid Association appointed a Task Force of experts to revise the original Medullary Thyroid Carcinoma: Management Guidelines of the American Thyroid Association.
Samuel A. Wells +17 more
semanticscholar +1 more source
Anaplastic Thyroid Carcinoma [PDF]
Frontiers in Endocrinology, 2012 Thyroid cancers represent about 1% of all human cancers. Differentiate thyroid carcinomas (DTCs), papillary and follicular cancers, are the most frequent forms, instead Anaplastic Thyroid Carcinoma (ATC) is estimated to comprise 1-2% of thyroid malignancies and it accounts for 14-39% of thyroid cancer deaths. The annual incidence of ATC is about one to
Taccaliti, Augusto +3 more
openaire +4 more sources
JAMA Oncology, 2016 IMPORTANCE Although growing evidence points to highly indolent behavior of encapsulated follicular variant of papillary thyroid carcinoma (EFVPTC), most patients with EFVPTC are treated as having conventional thyroid cancer.
Y. Nikiforov +30 more
semanticscholar +1 more source
BMC Surgery, 2019 Background In this study, we aimed to compare the kinetics of intact parathyroid hormone (iPTH) during the perioperative period of endoscopic thyroidectomy via bilateral areola approach (ETBAA) in the same period, following a traditional open ...
Daqi Zhang +7 more
doaj +1 more source
Frontiers in Cell and Developmental Biology, 2021 Novel therapy strategies are crucial for thyroid carcinoma treatment. It is increasingly important to clarify the mechanism of thyroid carcinoma progression.
Yang Liu +7 more
doaj +1 more source
Relationship between serum NDRG3 and papillary thyroid carcinoma
Frontiers in Endocrinology, 2022 BackgroundIn recent years, papillary thyroid carcinoma is considered to be one of the fastest increaseing cancer. NDRG family member 3 (NDRG3) has been proposed as a molecular marker of tumor, and is expected to be used in clinic.MethodsEnzyme-linked ...
Jiahao Wang +5 more
doaj +1 more source
Frontiers in Oncology, 2020 Patients with advanced thyroid carcinoma have poor prognosis with low overall survival. Unfortunately, the underlying mechanisms of thyroid carcinoma progression remain unclear.
Chang Liu +11 more
doaj +1 more source
Zhongliu Fangzhi Yanjiu, 2021 Papillary thyroid carcinoma is one of the most common thyroid cancer subtypes. Although papillary thyroid carcinoma can be treated effectively with excision, microwave ablation, radioactive iodine and hormone replacement therapy, these ways are ...
NIU Yanqiang +6 more
doaj +1 more source
Active Surveillance for T1bN0M0 Papillary Thyroid Carcinoma.
Thyroid, 2019 BACKGROUND Prospective trials of active surveillance for asymptomatic papillary microcarcinoma (T1aN0M0) since the 1990s have shown progression rates of only 5-10%.
T. Sakai +6 more
semanticscholar +1 more source